|
Our Members Know First!! Sign Up For The Hottest Newsletter!! XCEL,CHKP,CHRD,CLRT,CMED,CNXT
(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS :
(OTCBB: XCEL - Xcellink International Inc.)
(NASDAQ: CHKP - Check Point Software Technologies Ltd.)
(NASDAQ: CHRD - Chordiant Software, Inc.)
(NASDAQ: CLRT - Clarient, Inc.)
(NASDAQ: CMED - China Medical Technologies, Inc.)
(NASDAQ: CNXT - Conexant Systems, Inc.)
www.StockMarketingInc.com
To sign up for our free Profiles & Alerts :: visit http://www.StockMarketingInc.com
email us!! info@StockMarketingInc.com or call 1-866-583-8960
------------------------------------------------------------------------------------------------------------------------------------------------------------
(OTCBB: XCEL - Xcellink International Inc.)
LATEST NEWS!!
Xcellink Signs Agreement With Technology Giant 3i Infotech for iPhone Integration
LAS VEGAS, NV, Nov 10, 2009 -- Xcellink International Inc. (OTCBB: XCEL), a developer of a patented mobile payments & banking platforms, is pleased to announce that is has executed an agreement with 3i Infotech for the development and integration of its patented software with Apple's iPhone technology.
Work will be carried out by 3i Infotech's development team, and it is expected that the new technology will be ready for testing in early January 2010. The board of Xcellink is extremely excited by this relationship due in part to the 3i Infotech Group of Companies, which includes Regulus Group, a subsidiary of the global information technology company 3i Infotech, and one of North America's largest payment processors.
Regulus Group is one of the brightest stars in the payment processing industry providing statement and bill presentment services to clients in the financial services, health care, insurance, telecommunications, and utilities industries. Regulus handles about 2 billion paper and electronic transactions each year.
After the testing has been completed on the iPhone, the next step will be software development and integration for Research in Motion's Blackberry software and also for Nokia smart phones.
There are more than 40 million worldwide owners of the iPhone/iPod Touch platform, over 25 million blackberry subscribers and Nokia, the world's largest maker of smartphones, controlled 45 percent of the market in the second quarter of 2009.
A company spokesman commented, "Xcellink is building out its relationships with major providers of both software development and mobile technologies. Our goal is to have the majority of smart phone technologies integrated with our patented software, and roll out some of our products by year's end." About 3i Infotech 3i Infotech is a global Information Technology company, which provides technology solutions to over 1,500 customers in more than 50 countries across 5 continents, spanning a range of verticals -- Insurance, Financial Services, and Governments. 3i Infotech was promoted by the NYSE-listed ICICI Bank, India's largest private sector bank. The Company integrates its products and services to create customized solutions to allow you to undertake technology-based business transformation that allows reorganization in line with today's dynamic digital business environment. Please see http://www.3i-infotech.com About Xcellink Xcellink International Inc. is a developer of advanced platform-independent customer-centric payment systems and methodologies. Xcellink's patented system has the technical ability to replace all credit, debit, charge and smart cards, providing all functions of order, warehousing, delivery and payment for all types of goods and services in a customer-centric manner that is more efficient, economical, and secure than systems operating today. Xcellink's unique process enables customers, rather than the merchant, to initiate, control and pay for all transactions, without the need for credit cards, in real-time anywhere, anytime, and at a fraction of the cost of current transactions.
Please visit www.xcellink.com
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: CHKP - Check Point Software Technologies Ltd.)
LATEST NEWS!!
Check Point Awarded International Common Criteria EAL4 Certification for Full Disk Encryption
Check Point Data Security Solutions Ensure Customers Benefit From the Highest Encryption Standard
REDWOOD CITY, CA, Nov 09, 2009 -- Check Point(R) Software Technologies Ltd. (NASDAQ: CHKP), the worldwide leader in securing the Internet, today announced Check Point Endpoint Security(TM) Full Disk Encryption, Pointsec(R) PC 6.3.1 has received Common Criteria Evaluation Assurance Level 4 (EAL4) certification from the National Information Assurance Partnership (NIAP). Government agencies and security-conscious enterprises that require EAL4 certification can now benefit from the data protection Full Disk Encryption offers.
Full Disk Encryption provides the highest level of data security for laptops and PCs through a combination of pre-boot authentication and strong encryption algorithms. The solution can be deployed independently or as part of Check Point Endpoint Security, the first and only single agent that combines all the critical components for total security on the endpoint.
EAL4 certification is the highest standard level existing encryption products can receive, and indicates the product has passed a long and stringent evaluation process. The International Standard Organization initially adopted Common Criteria and uses EAL levels as global standards. EAL4 certification provides assurance to government agencies, and any organization protecting mission critical assets, that Check Point security solutions meet or exceed strict criteria. Many government agencies require data security solutions to have at the minimum EAL4 certification.
"Information on endpoint devices is most vulnerable to theft or loss, so to achieve complete protection, it's essential that an organization's endpoint security solution include data encryption," said Ben Khoushy, vice president of endpoint products at Check Point. "EAL4 certification not only allows additional government entities to benefit from Check Point's leading data encryption solutions, but also objectively validates the overall design and functionality of Check Point endpoint solutions. Full Disk Encryption ensures data remains protected, regulatory requirements are met and the organization's reputation stays intact." In addition to Full Disk Encryption for Windows, Mac OS X and Linux based computers, Check Point offers customers port and removable media protection through Check Point Media Encryption and mobile phone encryption through Pointsec Mobile. Check Point encryption products are quick and simple to deploy, scale to any size organization, are proven in many industry and government deployments around the world, and support the broadest set of platforms.
EAL4 certification for Full Disk Encryption is the latest of many industry standards Check Point products consistently meet. More information on third-party certifications received by Check Point can be found at: www.checkpoint.com/products/certifications/.
"Through Check Point, customers benefit from the industry's most secure security solutions, as demonstrated by Check Point's ability to consistently meet stringent industry certifications," concluded Khoushy.
About Check Point Software Technologies Ltd. Check Point Software Technologies Ltd. (www.checkpoint.com), worldwide leader in securing the Internet, is the only vendor to deliver Total Security for networks, data and endpoints, unified under a single management framework. Check Point provides customers uncompromised protection against all types of threats, reduces security complexity and lowers total cost of ownership. Check Point first pioneered the industry with FireWall-1 and its patented stateful inspection technology. Today, Check Point continues to innovate with the development of the Software Blade architecture. The dynamic Software Blade architecture delivers secure, flexible and simple solutions that can be fully customized to meet the exact security needs of any organization or environment. Check Point customers include tens of thousands of businesses and organizations of all sizes including all Fortune 100 companies. Check Point's award-winning ZoneAlarm solutions protect millions of consumers from hackers, spyware and identity theft.
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: CHRD - Chordiant Software, Inc.)
LATEST NEWS!!
Chordiant Software Named to FinTech 100 List of Financial Services Providers for Sixth Year in a Row
American Banker, Bank Technology News, and IDC Financial Insights Include Chordiant on List of Top Global Technology Providers to the Financial Services Industry
CUPERTINO, Calif., Nov 09, 2009 -- Chordiant Software, Inc. (Nasdaq:CHRD), the leading provider of Customer Experience (Cx(TM)) software and services, today announced that American Banker, Bank Technology News, and IDC Financial Insights, an independent research services firm, have included Chordiant in the sixth annual FinTech 100 rankings of the top global technology providers to the financial services industry. This year, Chordiant was ranked 73rd and has been ranked on the Fin Tech 100 every year since the list's inception.
"We are very pleased to be listed on the Fintech 100 for the sixth year in a row," said Steven R. Springsteel, chairman, president and CEO, Chordiant Software. "Our continuous inclusion clearly reflects the fact that global financial services companies turn to our customer experience solutions to improve their competitiveness, which is paramount during the current economic climate." The FinTech 100 includes vendors that derive more than one-third of eligible revenue from the financial services industry. All rankings are based on Financial Insights' revenue estimates including information provided by public and private companies. Financial Insights conducted analysis on more than 400 companies for this recognition.
To obtain a complete copy of the report, please visit: http://www.americanbanker.com/fintech100/ About Chordiant Software, Inc.
Chordiant Software, Inc. (Nasdaq:CHRD), the leading provider of Customer Experience (Cx(TM)) software and services optimizes the customer experience to help global brands multiply customer lifetime value. Chordiant arms marketing, customer service and customer loyalty executives with a suite of intelligent conversation management applications to deliver an order of magnitude improvement in customer experience. By maximizing the value of every conversation across all channels, Chordiant enables today's fast-paced brands to engage more effectively with customers and quickly measure whether business strategies are succeeding, resulting in faster acquisition, improved competitiveness, less churn, and superior customer service.
For more information please visit www.chordiant.com.
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: CLRT - Clarient, Inc.)
LATEST NEWS!!
ALISO VIEJO, Calif., Nov 09, 2009 -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make presentations at two upcoming investor conferences in New York City.
The first presentation will be made at the Lazard Capital Markets Sixth Annual Healthcare Conference at 1:40 pm EST on Tuesday, November 17. The conference will be held at the St. Regis Hotel November 17-18.
The second presentation will be made at the 21st Annual Piper Jaffray Health Care Conference at 10:30 am EST on Wednesday, December 2. The conference will be held at the New York Palace Hotel December 1-2.
Live webcasts of the Company's presentations at the conferences will be available via a link provided at http://www.clarientinc.com/investor. Archived replays of the presentations will also be available shortly after the presentation time for a period of at least 60 days.
About Clarient Clarient combines innovative diagnostic technologies with world-class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by collaborating with the healthcare community to translate cancer research and development into better patient care. Clarient's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. The rise of individualized medicine has created the need for a centralized resource which provides leading oncology diagnostic technologies, such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory, which provides the most advanced oncology testing and diagnostic services available. Resulting diagnostic reports and analyses are made available to customers through Clarient's Internet-based portal, PATHSiTE(TM). Clarient also plans to develop and market new, proprietary "companion" diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, and leukemia/lymphoma. www.clarientinc.com
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: CMED - China Medical Technologies, Inc.)
LATEST NEWS!!
China Medical Technologies Receives SFDA Approval for its Leukemia BCR/ABL Fusion Gene Detection FISH Probe
BEIJING, Nov 09, 2009 / -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH Probe") from the State Food and Drug Administration of China (the "SFDA"). The Leukemia BCR/ABL FISH Probe is a molecular diagnostic test kit that uses DNA probes for accurate detection of Philadelphia translocation, which is a specific chromosomal abnormality associated with chronic myelogenous leukemia ("CML"), acute lymphoblastic leukemia ("ALL") and acute myelogenous leukemia ("AML"). Philadelphia translocation is the result of a reciprocal translocation between chromosomes 9 and 22. The translocation results in the presence of a fusion gene which is created by juxtapositioning of a part of the breakpoint cluster region ("BCR") gene from chromosome 22 to the Abelson ("ABL") gene on chromosome 9. CML, ALL and AML are some of the most common types of leukemia, and detecting Philadelphia translocation is a critical diagnosis and prognosis guidance for selecting different treatment protocols for patients with CML, ALL and AML.
As of today, the Company has received SFDA approvals for all the major FISH probes that the Company acquired as part of the FISH business in March 2007, which include HER-2 FISH Probe, Prenatal FISH Probe, Cervical Cancer FISH Probe, Bladder Cancer FISH Probe and Leukemia BCR/ABL FISH Probe. The FISH probes that the Company developed after its acquisition of the FISH business in March 2007, such as the EGFR molecular diagnostic kits, Prostate Cancer FISH Probe, Lymphoma FISH Probe, Sarcoma FISH Probe and FISH probes related to other forms of leukemia, are either in the clinical trial stage or under SFDA review.
"We believe we have become a leading developer and manufacturer of FISH probes in China with the most comprehensive FISH probes for clinical screening, diagnosis and prognosis," commented Mr. Xiaodong Wu, Chairman and Chief Executive Officer of the Company. "We believe our FISH probes will continue to drive a healthy growth for our company by generating sustainable and recurring revenue. We are also confident that our newly developed FISH probes will be approved by the SFDA in the future on a timely basis." About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com .
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: CNXT - Conexant Systems, Inc.)
LATEST NEWS!!
Conexant Wins 2009 Green Supply Chain Award
Company's Green Business Practices Recognized by Supply & Demand Chain Executive Magazine
NEWPORT BEACH, Calif., Nov 09, 2009 -- Conexant Systems, Inc. (NASDAQ: CNXT), a leading supplier of innovative semiconductor solutions for imaging, audio, embedded-modem, and video applications, today announced that it won a 2009 Green Supply Chain Award from Supply & Demand Chain Executive (SDCE) magazine. Conexant was recognized for implementing a "green" or sustainable supply chain strategy within its own organization. Winners were selected based on a variety of criteria including the impact of the results to date, and projected results.
"We are proud to have earned SDCE's 2009 Green Supply Chain Award in this year's competition," said Sailesh Chittipeddi, co-president of Conexant. "Conexant is committed to the preservation of the environment and the health and safety of our employees, and we will continue to implement green business initiatives that support this pledge. The cost-savings we have achieved to date with our green initiatives also support our operational financial objectives, and demonstrate that environmentally friendly practices can also be good for business." In order to achieve its goals, Conexant developed a Social and Environmental Management System (SEMS) that is used as framework to develop and manage programs that prevent pollution, minimize the company's overall environmental impact, reduce health and safety risks, promote integrity and fair labor practice, and continually improve business practices and performance. Conexant's SEMS is certified to ISO 14001:2004 (International Organization for Standardization - Environmental Management Systems) and conforms to the requirements of OHSAS 18001:2007 (Occupational Health and Safety Administration Standard - Health and Safety Management Systems), and the EICC (Electronic Industry Citizenship Coalition - Electronic Industry Code of Conduct).
Conexant's recent environmentally friendly accomplishments include: -- Achieving greater than 98 percent compliance meeting restriction of hazardous substances (RoHS)/green requirements for legacy products, and 100 percent compliancy for all new products.
-- Reducing energy consumption throughout worldwide facilities by at least 10 percent, while reducing carbon emissions by hundreds of tons per year through initiatives that reduced power requirements for lighting, AC/heating, computing, printing, and data storage.
-- Reducing energy consumption and air emissions from employee travel by approximately 57 percent through the use of various work-collaboration tools -- Lowering fuel/emissions/impact on landfills by reducing the amount of packing materials by 60 percent.
-- Increasing the use of post-consumer recycled materials by approximately 25 percent.
About Conexant Conexant's comprehensive portfolio of innovative semiconductor solutions includes products for imaging, audio, embedded-modem, and video applications. Conexant is a fabless semiconductor company headquartered in Newport Beach, Calif. For more information, visit www.conexant.com.
------------------------------------------------------------------------------------------------------------------------------------------------------------
About StockMarketingInc.com
StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ Back to the Communication Solutions Community's Homepage ]
|
Activate Email 
INDUSTRIES
